Medical providers seeking to expand their expertise into aesthetic medicine can gain comprehensive knowledge and hands-on experience through an introductory Botox® training course. These courses typically cover foundational knowledge, clinical skills, safety practices, and business aspects, providing a solid starting point for practitioners looking to offer this popular aesthetic treatment to their patients.

A groundbreaking head-to-head trial comparing Eli Lilly’s Zepbound® (tirzepatide) and Novo Nordisk’s Wegovy® (semaglutide) has revealed Zepbound’s superior efficacy in weight loss treatment. In this Lilly-sponsored study of 751 participants over 72 weeks, Zepbound users achieved an average weight loss of 20.2%, significantly outperforming the Wegovy group’s 13.7% reduction.